Overall market situation:
Sentiment during the first session this week in Europe is very good. DE40 contracts are currently gaining 1%, while FRA40 and UK100 are adding 0.27% and 0.3% respectively. The economic calendar is empty today, so investors will focus on quarterly company results and possible information on tariffs in the world.
Distribution of today’s rates of return for companies from Europe. Source: xStation
The German DE40 index is gaining 1.0% today on an intraday basis. The key element in analyzing further, potential index behavior may be the element of further demand and supply behavior at the previously tested barrier of 20,000 points, which may decide whether the further downward trend will continue or whether we will see an attempt to return to permanent growth, if the price manages to stay above this zone permanently. Source: xStation
News:
European shares are gaining during Monday’s trading session. The positive sentiment is visible primarily in the technology sector, which is gaining after the US decided not to impose high tariffs on phones and semiconductors. This decision means that today it is the high tech sector that is doing best.
Source: xStation
In the context of individual companies, it is worth mentioning Novo Nordisk (NOVOB.DK), which is gaining 3.5% after Pfizer decided to abandon the development of its obesity drug. The drop in competition is good news for Novo Nordisk, which has recently been subjected to a very high concentration of its revenue structure in the field of obesity drugs.
Source: xStation
Other news from companies included in the DAX index. Source: Bloomberg Financial LP
The material on this page does not constitute financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other specific needs. All information provided, including opinions, market research, mathematical results and technical analyzes published on the Website or transmitted To you by other means, it is provided for information purposes only and should in no way be construed as an offer or solicitation for a transaction in any financial instrument, nor should the information provided be construed as advice of a legal or financial nature on which any investment decisions you make should be based exclusively To your level of understanding, investment objectives, financial situation, or other specific needs, any decision to act on the information published on the Website or sent to you by other means is entirely at your own risk if you In doubt or unsure about your understanding of a particular product, instrument, service or transaction, you should seek professional or legal advice before trading. Investing in CFDs carries a high level of risk, as they are leveraged products and have small movements Often the market can result in much larger movements in the value of your investment, and this can work against you or in your favor. Please ensure you fully understand the risks involved, taking into account investments objectives and level of experience, before trading and, if necessary, seek independent advice.
